Evidence as a commercial tool

Symphony Environmental Technologies (LSE:SYM) sells additives that are designed to make conventional plastics biodegrade, a claim that regulators in many countries treat with caution. Its announcements in September 2026 show how the company is trying to address that scepticism: by assembling independent laboratory evidence and using it to secure acceptance from governments, market by market.

The business

Symphony, whose shares trade on AIM under the code SYM, develops and sells masterbatch additives for plastics. Its main product, d2w, is added to polyolefin plastics such as polyethylene and polypropylene so that items can break down in open environments; the company says this happens without leaving microplastics or toxins. A second range, d2p, covers other additive functions; on 15 September 2026 the company issued an announcement on test results and a first order for a d2p ethylene adsorber. Symphony sells mainly through distributors and licensees, and its key markets include the Middle East, where it has restructured to a direct sales model, Latin America, Asia and India, where a joint venture is awaiting certification.

The latest announcements

On 28 September 2026, Symphony reported completion of a programme of ten independent studies carried out between 2024 and 2026 by ISO 17025 accredited laboratories, nine by Intertek and one by CIQA, a Mexican public laboratory. The company said the studies showed 98.7% aerobic and 91.06% anaerobic biodegradation, no ecotoxicity in tests on terrestrial plants and earthworms, no residual plastic or microplastics, and that products could be recycled with ordinary plastic. Chief executive Michael Laurier called the programme "one of the most comprehensive packages of evidence available."

On 22 September, the company said Colombia's Ministry of Environment and Sustainable Development had accepted evidence of biodegradability and non-toxicity for polypropylene drinking straws made by its customer Promociones Fantasticas using d2w. The acceptance was given under Colombian rules that allow biodegradable alternatives to banned single-use plastics if they meet set criteria. Laurier described it as "an important breakthrough after a lengthy and detailed process to satisfy the Colombian authorities." The company also issued an announcement titled confirmed compliance with a Mexican standard on 17 September.

Financial position

On 16 September 2026, Symphony reported results for the six months to 30 June 2026. Revenue rose 23% to £3.608 million from £2.925 million, with d2w masterbatch sales up 20% to £3.030 million and d2p sales up 21% to £289,000. Gross Margin improved to 59% from 51%, and the company recorded a pre-tax profit of £55,000 compared with a loss of £503,000 a year earlier. Cash was £785,000 at the period end and current borrowings were £3.416 million, including a convertible Loan of £1.8 million that has been extended to 31 January 2027. Net Assets were negative at £751,000. The chairman said the group had delivered a much improved set of results, and the company said it enters the second half with a better operating platform, improved gross margins, reduced cash outflow and a return to profitability.

Risks and uncertainties

The Balance Sheet is the immediate concern: negative net assets, limited cash and borrowings due within a year mean the company depends on lenders' continued support or new funding. Commercially, a single acceptance for drinking straws in Colombia is narrow, and turning regulatory evidence into larger orders is not assured. Oxo-biodegradable additives remain contested in some jurisdictions, so regulatory reception elsewhere is uncertain.

Conclusion

Symphony is building a scientific dossier, now ten studies deep, and using it to secure product-by-product approvals such as the Colombian decision. Its first-half return to a small profit and higher margins show some commercial progress, but the reported finances suggest the company needs these regulatory gains to translate into Volume relatively quickly while its Debt is addressed.